Motor Complications in Parkinson's Disease

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial

(2011) Hideyuki Sawada et al.   PLoS One

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

(2010) Fabrizio Stocchi et al.   ANNALS OF NEUROLOGY

Deep Brain Stimulation for Parkinson Disease

(2010) Jeff M. Bronstein et al.   ARCHIVES OF NEUROLOGY

Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

(2010) Martin Wolz et al.   JOURNAL OF NEURAL TRANSMISSION

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

(2010) Paolo Calabresi et al.   LANCET NEUROLOGY

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease

(2010) P. Stathis et al.   MOVEMENT DISORDERS

Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease

(2010) Kenneth A. Follett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

NMDA antagonist memantine improves levodopa-induced dyskinesias and “On-off” phenomena in Parkinson's disease

(2009) Sara Varanese et al.   MOVEMENT DISORDERS

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS